title: F-18 FDG uptake by recurrent Hürthle cell carcinoma of the thyroid using high-energy planar scintigraphy.
abstract: F-18-2-deoxy-2-fluoro-D-glucose (FDG) has been reported to localize in various tumors. Localization or recurrent Hürthle cell cancer with FDG is described. An unsuccessful attempt was made to image this patient's tumor with I-131 and Tc-99m MIBI. Because of the patient's size, he could not be accommodated in the PET camera apperature. Use of a planar high energy gamma camera facilitated detection and ultimate treatment.
authors.affiliation: Nuclear Medicine Department, William Beaumont Hospital, Royal Oak, MI 48073-6769, USA.
authors.forename: C L
authors.initials: CL
authors.lastname: Blount
authors.forename: H J
authors.initials: HJ
authors.lastname: Dworkin
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000000981:diagnostic imaging*; D003847:Deoxyglucose / Q000031:analogs & derivatives*; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D015902:Gamma Cameras; D006801:Humans; D007457:Iodine Radioisotopes; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging*; D009767:Obesity, Morbid / Q000150:complications; D011877:Radionuclide Imaging; D017256:Technetium Tc 99m Sestamibi; D013964:Thyroid Neoplasms / Q000150:complications / Q000000981:diagnostic imaging*
chemical_list: D005462:Fluorine Radioisotopes; D007457:Iodine Radioisotopes; D019788:Fluorodeoxyglucose F18; D017256:Technetium Tc 99m Sestamibi; D003847:Deoxyglucose